NASDAQ: DERM
Journey Medical Corp Stock Ownership - Who owns Journey Medical?

Insider buying vs selling

Have Journey Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claude MaraouiPresident CEO2025-08-251,250,000$0.07
$81.25kBuy
Claude MaraouiPresident CEO2025-08-2510,877$7.47
$81.25kSell

1 of 1

DERM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DERM insiders and whales buy or sell their stock.

DERM Shareholders

What type of owners hold Journey Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fortress Biotech Inc15.04%4,110,467$20.55MInsider
Claude Maraoui8.91%2,435,990$12.18MInsider
Tang Capital Management LLC6.79%1,854,596$9.27MInstitution
Wasatch Advisors LP4.82%1,316,275$6.58MInstitution
Opaleye Management Inc3.57%975,000$4.88MInstitution
J Goldman Co LP2.92%798,366$3.99MInstitution
Vanguard Group Inc2.80%764,147$3.82MInstitution
Blackrock Inc2.63%719,784$3.60MInstitution
Ramsey Alloush2.19%598,543$2.99MInsider
Millennium Management LLC1.68%457,812$2.29MInstitution

1 of 3

DERM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DERM40.33%31.36%Net Buying
CRDL9.08%0.00%
ASRT9.54%90.46%Net SellingNet Selling
OGI7.93%0.00%
LFCR49.12%50.88%Net SellingNet Selling

Journey Medical Stock Ownership FAQ

Who owns Journey Medical?

Journey Medical (NASDAQ: DERM) is owned by 40.33% institutional shareholders, 31.36% Journey Medical insiders, and 28.31% retail investors. Fortress Biotech Inc is the largest individual Journey Medical shareholder, owning 4.11M shares representing 15.04% of the company. Fortress Biotech Inc's Journey Medical shares are currently valued at $20.59M.

If you're new to stock investing, here's how to buy Journey Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.